丽人丽妆(605136) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was ¥360,948,233.43, a decrease of 23.58% compared to ¥472,339,124.63 in the same period last year[4] - The net loss attributable to shareholders was ¥18,321,991.88, compared to a loss of ¥9,546,080.31 in the previous year[4] - The basic and diluted earnings per share were both -¥0.05, down from -¥0.02 year-on-year[6] - The net profit for Q1 2025 was -¥18,690,085.67, compared to -¥9,960,529.56 in Q1 2024, indicating a significant increase in losses of approximately 87% year-over-year[19] - The total comprehensive income for Q1 2025 was -¥18,893,092.85, compared to -¥9,493,790.81 in Q1 2024, reflecting a 99% increase in comprehensive losses[19] Cash Flow and Liquidity - The net cash flow from operating activities was -¥551,475.19, a decline of 132.06% from ¥1,720,181.29 in the previous year[4] - Cash and cash equivalents decreased to CNY 580,752,658.41 as of March 31, 2025, from CNY 833,765,764.39 at the end of 2024, a decline of 30.3%[14] - Cash and cash equivalents at the end of Q1 2025 were ¥637,316,773.73, down from ¥1,190,550,032.02 at the end of Q1 2024, representing a decrease of approximately 46%[22] - Operating cash flow for Q1 2025 was -¥551,475.19, a decline from a positive cash flow of ¥1,720,181.29 in Q1 2024[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,641,440,873.90, a decrease of 3.91% from ¥2,748,938,027.69 at the end of the previous year[6] - Total assets as of March 31, 2025, were CNY 2,641,440,873.90, down from CNY 2,748,938,027.69 at the end of 2024[15] - Total liabilities decreased to CNY 183,181,885.45 from CNY 271,785,946.40, a reduction of 32.5%[16] - The company's total equity as of March 31, 2025, was CNY 2,458,258,988.45, slightly down from CNY 2,477,152,081.29 at the end of 2024[16] Operating Costs and Expenses - Total operating costs for Q1 2025 were CNY 367,860,933.84, down 23.5% from CNY 480,555,239.37 in Q1 2024[18] - Operating costs included CNY 220,897,425.39 in cost of goods sold, a decrease of 31.5% from CNY 322,229,915.90 in the previous year[18] - Research and development expenses for Q1 2025 were CNY 5,764,334.96, slightly down from CNY 6,172,733.63 in Q1 2024[18] - The company reported operating expenses of ¥465,571,611.61 in Q1 2025, compared to ¥708,681,080.61 in Q1 2024, showing a reduction in operating expenses by approximately 34%[21] Investment Activities - The company had a net cash outflow from investing activities of -¥161,174,250.67 in Q1 2025, compared to -¥361,580.57 in Q1 2024, indicating a significant increase in investment expenditures[22] Brand and Market Development - The company's self-owned brand business grew over 110% compared to the same period last year[13] - The company has expanded its agency business since the second half of 2024, collaborating with brands such as Ongredients and GEOMAR[13] - The company has plans for market expansion and new product development, although specific details were not disclosed in the financial report[18] Impairment and Non-Operating Income - The company incurred an asset impairment loss of -¥17,111,154.69 in Q1 2025, compared to -¥8,385,807.21 in Q1 2024, reflecting a 104% increase in impairment losses[19] - The company reported non-operating income of ¥853,152.83, primarily from government subsidies and other non-recurring gains[7]